Genetics and Heart Failure: A Concise Guide for the Clinician
暂无分享,去创建一个
J. Berg | B. Jensen | C. Skrzynia | M. Willis
[1] Heidi L Rehm,et al. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. , 2013, The Journal of molecular diagnostics : JMD.
[2] E. McNally,et al. Genetic mutations and mechanisms in dilated cardiomyopathy. , 2013, The Journal of clinical investigation.
[3] Donald Wolfgeher,et al. Population-Based Variation in Cardiomyopathy Genes , 2012, Circulation. Cardiovascular genetics.
[4] Deborah A Nickerson,et al. Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome Era , 2012, Circulation. Cardiovascular genetics.
[5] Nicole M. Johnson,et al. Genetic testing for dilated cardiomyopathy in clinical practice. , 2012, Journal of cardiac failure.
[6] D. Lanfear,et al. Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges , 2012, Current Heart Failure Reports.
[7] L. Mestroni,et al. Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.
[8] A. Zwinderman,et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.
[9] J. Lupski,et al. Human genome sequencing in health and disease. , 2012, Annual review of medicine.
[10] G. Dorn,et al. Clinical considerations of heritable factors in common heart failure. , 2011, Circulation. Cardiovascular genetics.
[11] R. Hershberger,et al. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[12] Joel N Hirschhorn,et al. Genome-wide association studies: results from the first few years and potential implications for clinical medicine. , 2011, Annual review of medicine.
[13] E. Boerwinkle,et al. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients , 2011, Pharmacogenetics and genomics.
[14] Eric Boerwinkle,et al. Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry: A Prospective Meta-Analysis From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2010, Circulation. Cardiovascular genetics.
[15] T. Callis,et al. Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all , 2010, Expert review of molecular diagnostics.
[16] Joseph T. Glessner,et al. Common Variants in HSPB7 and FRMD4B Associated With Advanced Heart Failure , 2010, Circulation. Cardiovascular genetics.
[17] F. Chiang,et al. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure , 2010, The Pharmacogenomics Journal.
[18] D. Judge. Use of genetics in the clinical evaluation of cardiomyopathy. , 2009, JAMA.
[19] C. Patterson. A Good Idea: A Physician’s Perspective on Genetic Counseling for Hypertrophic Cardiomyopathy , 2009, Journal of cardiovascular translational research.
[20] S. Kardia,et al. Clinical and genetic modifiers of long-term survival in heart failure. , 2009, Journal of the American College of Cardiology.
[21] Ana Morales,et al. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2009, Circulation. Heart failure.
[22] F. Collins,et al. The HapMap and genome-wide association studies in diagnosis and therapy. , 2009, Annual review of medicine.
[23] Sekar Kathiresan,et al. HapMap and Mapping Genes for Cardiovascular Disease , 2008, Circulation. Cardiovascular genetics.
[24] E. Bleecker,et al. A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors. , 2008, Pharmacogenetics and genomics.
[25] J. Spertus,et al. A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure , 2008, Nature Medicine.
[26] S. Kardia,et al. Abstract 2001: Genetic {beta}-Blockade: A G-Protein Coupled Receptor Kinase-5 Polymorphism That Inhibits Beta-Adrenergic Receptor Signaling is Protective in Heart Failure , 2006 .
[27] D. Conrad,et al. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome , 2006, Nature Genetics.
[28] D. Levy,et al. Association of parental heart failure with risk of heart failure in offspring. , 2006, The New England journal of medicine.
[29] R. Bennett,et al. A New Definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force Report , 2006, Journal of Genetic Counseling.
[30] G. MacGowan,et al. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. , 2004, Journal of the American College of Cardiology.
[31] Tianlun Yang,et al. Association of the angiotensin‐converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients , 2004, European journal of heart failure.
[32] G. Dorn,et al. β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure , 2003, Nature Medicine.
[33] S. Ball,et al. An evaluation of the beta‐1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT‐HF sub‐study , 2003, European journal of heart failure.
[34] V. Cameron,et al. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. , 2003, Journal of the American College of Cardiology.
[35] P. Insel,et al. Blunted Cardiac Responses to Receptor Activation in Subjects With Thr164Ile &bgr;2-Adrenoceptors , 2001, Circulation.
[36] T. McIntosh,et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. , 1998, The Journal of clinical investigation.
[37] S. Green,et al. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Sylvén,et al. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. , 1996, Journal of the American College of Cardiology.
[39] N. Iwai,et al. DD Genotype of the Angiotensin‐Converting Enzyme Gene Is a Risk Factor for Left Ventricular Hypertrophy , 1994, Circulation.
[40] T. Ogihara,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[41] H. Schunkert,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[42] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[43] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[44] W. Belloso,et al. [Cardiovascular pharmacogenomics]. , 2014, Archivos de cardiologia de Mexico.
[45] H. Watkins,et al. The Genomic Architecture of Sporadic Heart Failure , 2011 .
[46] C. O’Donnell,et al. Genomics of heart failure. , 2010, Heart failure clinics.
[47] Joseph T. Glessner,et al. Common Variants in HSPB 7 and FRMD 4 B Associated With Advanced Heart Failure , 2010 .
[48] Julie A. Johnson,et al. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure. , 2007, Pharmacogenetics and genomics.
[49] L. Lazzeroni,et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. , 2006, Proceedings of the National Academy of Sciences of the United States of America.